U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
VISILIZUMAB
INN   USAN   WHO-DD  
USAN   INN  
Official Name English
visilizumab [INN]
Preferred Name English
VISILIZUMAB [USAN]
Common Name English
IMMUNOGLOBULIN G2 (HUMAN-MOUSE MONOCLONAL HUM291 .GAMMA.2-CHAIN ANTI-HUMAN ANTIGEN CD3), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL HUM291 .KAPPA.-CHAIN, DIMER
Common Name English
HUM-291
Code English
MAB HUMANIZED (IGG2) ANTI P09693 (CD3G_HUMAN) (HUM291)
Common Name English
NUVION
Brand Name English
HUM291
Code English
IMMUNOGLOBULIN G2 (HUMAN-MOUSE MONOCLONAL HUM291 .GAMMA.2-CHAIN ANTI-HUMAN ANTIGEN CD3), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL HUM291 .KAPPA.-CHAIN, DIMER
Common Name English
Visilizumab [WHO-DD]
Common Name English
MAB HUMANIZED TO CD3+ T CELLS
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C20401
Created by admin on Mon Mar 31 20:55:59 GMT 2025 , Edited by admin on Mon Mar 31 20:55:59 GMT 2025
Code System Code Type Description
FDA UNII
H18SKU3289
Created by admin on Mon Mar 31 20:55:59 GMT 2025 , Edited by admin on Mon Mar 31 20:55:59 GMT 2025
PRIMARY
USAN
KK-166
Created by admin on Mon Mar 31 20:55:59 GMT 2025 , Edited by admin on Mon Mar 31 20:55:59 GMT 2025
PRIMARY
SMS_ID
100000137406
Created by admin on Mon Mar 31 20:55:59 GMT 2025 , Edited by admin on Mon Mar 31 20:55:59 GMT 2025
PRIMARY
DRUG BANK
DB12053
Created by admin on Mon Mar 31 20:55:59 GMT 2025 , Edited by admin on Mon Mar 31 20:55:59 GMT 2025
PRIMARY
INN
8054
Created by admin on Mon Mar 31 20:55:59 GMT 2025 , Edited by admin on Mon Mar 31 20:55:59 GMT 2025
PRIMARY
ChEMBL
CHEMBL2108811
Created by admin on Mon Mar 31 20:55:59 GMT 2025 , Edited by admin on Mon Mar 31 20:55:59 GMT 2025
PRIMARY
WIKIPEDIA
VISILIZUMAB
Created by admin on Mon Mar 31 20:55:59 GMT 2025 , Edited by admin on Mon Mar 31 20:55:59 GMT 2025
PRIMARY
EVMPD
SUB75525
Created by admin on Mon Mar 31 20:55:59 GMT 2025 , Edited by admin on Mon Mar 31 20:55:59 GMT 2025
PRIMARY
CAS
219716-33-3
Created by admin on Mon Mar 31 20:55:59 GMT 2025 , Edited by admin on Mon Mar 31 20:55:59 GMT 2025
PRIMARY
NCI_THESAURUS
C2229
Created by admin on Mon Mar 31 20:55:59 GMT 2025 , Edited by admin on Mon Mar 31 20:55:59 GMT 2025
PRIMARY
ACTIVE MOIETY
VISILIZUMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966